Key Insights

Highlights

Success Rate

84% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

13.6%

3 terminated out of 22 trials

Success Rate

84.2%

-2.3% vs benchmark

Late-Stage Pipeline

36%

8 trials in Phase 3/4

Results Transparency

44%

7 of 16 completed with results

Key Signals

7 with results84% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (7)
P 1 (3)
P 2 (2)
P 3 (4)
P 4 (4)

Trial Status

Completed16
Terminated3
Recruiting1
Unknown1
Withdrawn1

Trial Success Rate

84.2%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT06985342Phase 4TerminatedPrimary

Acute Migraine Treatment in the ED With Gepants

NCT07292090Not ApplicableRecruiting

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study

NCT02098499Phase 4WithdrawnPrimary

Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT

NCT05536635Not ApplicableCompletedPrimary

Effect of Breathing Techniques on Migraine Attacks and Severity

NCT02351544Not ApplicableCompletedPrimary

Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches

NCT06342232Not ApplicableCompletedPrimary

The Efficacy of Neurofeedback Mindfulness in Migraine Management

NCT02856802Phase 2CompletedPrimary

An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)

NCT00355056Not ApplicableCompletedPrimary

PREMIUM Migraine Trial

NCT01629329Phase 4TerminatedPrimary

Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine

NCT01706003CompletedPrimary

The Utility of Telemedicine in the Management of Migraine

NCT00750594CompletedPrimary

Patent Foramen Ovale in Children With Migraine Headaches

NCT02057315Phase 1CompletedPrimary

Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine

NCT00960245Phase 1Completed

Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions

NCT01118988Not ApplicableCompleted

Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents

NCT01944059Phase 4TerminatedPrimary

Theramine® in the Prevention of Migraine Headache

NCT02629536Phase 3UnknownPrimary

Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study.

NCT00714727Phase 1CompletedPrimary

Set Point Acupuncture for Migraines Using a Digital Assistant

NCT00665236Not ApplicableCompletedPrimary

Craniosacral Therapy in Migraine: A Feasibility Study

NCT00109083Phase 2CompletedPrimary

A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

NCT00442221Phase 3CompletedPrimary

The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months

Scroll to load more

Research Network

Activity Timeline